HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up
ZACKS· 2025-11-04 14:55
Key Takeaways Henry Schein posted Q3 adjusted EPS of $1.38, up 13.1% year over year, beating consensus by 8.7%. HSIC Q3 net sales rose 5.4% to $3.34B, surpassing estimates on strength across distribution and tech segments.HSIC lifted 2025 EPS outlook to $4.88-$4.96 and revenue growth forecast to 3-4%. Henry Schein, Inc. (HSIC) registered third-quarter 2025 adjusted earnings per share (EPS) of $1.38, up 13.1% from the year-ago period’s figure. The bottom line also surpassed the Zacks Consensus Estimate by 8. ...
AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-04 14:55
AC Immune (ACIU) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.2 per share when it actually produced a loss of $0.25, delivering a surprise of -25%.Over the last four quarters, the company ...
Silicon Laboratories (SLAB) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2025-11-04 14:55
Silicon Laboratories (SLAB) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to a loss of $0.13 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +6.67%. A quarter ago, it was expected that this chipmaker would post earnings of $0.09 per share when it actually produced earnings of $0.11, delivering a surprise of +22.22%.Over the last four quarters, the com ...
Reservoir Media, Inc. (RSVR) Q2 Earnings Lag Estimates
ZACKS· 2025-11-04 14:55
Reservoir Media, Inc. (RSVR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -40.00%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.01, delivering no surprise.Over the last four quarters, the company has ...
Intuitive Surgical Stock To $700?
Forbes· 2025-11-04 14:55
CHONGQING, CHINA - JULY 19: In this photo illustration, a person holds a smartphone displaying the logo of Intuitive Surgical Inc. (NASDAQ: ISRG) in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)Getty ImagesIntuitive Surgical (ISRG) has been on a powerful run, fueled by rising adoption of its da Vinci robotic systems and steady growth in surgical procedure volumes worldwide. The stock has outpaced both the S&P 500 and the broader medtech sector, underscoring investor confidence in its lead ...
Sarepta Therapeutics shares plunge after disappointing trial data
Invezz· 2025-11-04 14:55
Sarepta Therapeutics Inc. shares plunged 37% on Tuesday after the biotechnology company reported disappointing trial results for two of its treatments targeting Duchenne muscular dystrophy (DMD). The ... ...
Should You Buy GoodRx Stock?
Forbes· 2025-11-04 14:55
Here’s why we believe GoodRx (GDRX) stock is worth considering: It is expanding, generating cash, and is available at a notable valuation discount. Let’s examine the figures.Cash Yield: GoodRx presents an impressive cash flow yield of 10.0%.Growing: The revenue growth over the last 12 months stands at 3.2%, which isn't remarkable, but your cash reserves are likely to increase.Valuation Discount: GDRX stock is currently priced at 35% below its 3-month high, 46% under its 1-year high, and 63% lower than its 2 ...
Pfizer's Q3 Earnings Beat on Top and Bottom Lines
247Wallst· 2025-11-04 14:54
Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected. ...
Candel Therapeutics to highlight immunotherapy advances at SITC 2025
Proactiveinvestors NA· 2025-11-04 14:54
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
DIVEVOLK Drops SeaTouch 4 Max V2 with Pro-Level Upgrades!
Globenewswire· 2025-11-04 14:54
SHENZHEN, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- DIVEVOLK, a leader in underwater imaging and diving technology, today announced the launch of the SeaTouch 4 Max Platinum V2, a significant upgrade to its flagship underwater smartphone housing. Engineered in direct response to community feedback, the V2 enhances durability, expands creative versatility with new mounting points, and improves ergonomics, all while retaining the patented full touchscreen functionality that allows divers unrestricted access to ...